MC 510051
Alternative Names: MF-EA-371 alphaLatest Information Update: 03 Oct 2000
At a glance
- Originator Daiichi Pharmaceutical; Essential Therapeutics [CEASED]
- Class Antibacterials
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pseudomonal infections
Most Recent Events
- 02 Oct 2000 Discontinued-Preclinical for Pseudomonal infections in USA (Unknown route)